Qingdao Haier (China) Performance
| 688139 Stock | 33.28 0.36 1.09% |
On a scale of 0 to 100, Qingdao Haier holds a performance score of 10. The company holds a Beta of 0.0094, which implies not very significant fluctuations relative to the market. As returns on the market increase, Qingdao Haier's returns are expected to increase less than the market. However, during the bear market, the loss of holding Qingdao Haier is expected to be smaller as well. Please check Qingdao Haier's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Qingdao Haier's historical price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Haier Biomedical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Qingdao Haier sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Payout Ratio 0.4558 | Ex Dividend Date 2024-06-06 |
| Begin Period Cash Flow | 931.2 M |
Qingdao |
Qingdao Haier Relative Risk vs. Return Landscape
If you would invest 2,483 in Qingdao Haier Biomedical on September 1, 2024 and sell it today you would earn a total of 845.00 from holding Qingdao Haier Biomedical or generate 34.03% return on investment over 90 days. Qingdao Haier Biomedical is generating 0.602% of daily returns and assumes 4.4947% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than Qingdao, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Qingdao Haier Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qingdao Haier's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Qingdao Haier Biomedical, and traders can use it to determine the average amount a Qingdao Haier's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1339
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688139 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.49 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.6 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Qingdao Haier is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qingdao Haier by adding it to a well-diversified portfolio.
Qingdao Haier Fundamentals Growth
Qingdao Stock prices reflect investors' perceptions of the future prospects and financial health of Qingdao Haier, and Qingdao Haier fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qingdao Stock performance.
| Return On Equity | 0.0816 | ||||
| Return On Asset | 0.0326 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 8.78 B | ||||
| Shares Outstanding | 317.95 M | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 4.73 X | ||||
| Revenue | 2.28 B | ||||
| Gross Profit | 1.38 B | ||||
| EBITDA | 398.4 M | ||||
| Net Income | 406.07 M | ||||
| Total Debt | 20.8 M | ||||
| Book Value Per Share | 13.74 X | ||||
| Cash Flow From Operations | 249.26 M | ||||
| Earnings Per Share | 1.13 X | ||||
| Total Asset | 5.53 B | ||||
| Retained Earnings | 1.86 B | ||||
About Qingdao Haier Performance
By analyzing Qingdao Haier's fundamental ratios, stakeholders can gain valuable insights into Qingdao Haier's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Qingdao Haier has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Qingdao Haier has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Qingdao Haier is entity of China. It is traded as Stock on SHG exchange.Things to note about Qingdao Haier Biomedical performance evaluation
Checking the ongoing alerts about Qingdao Haier for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Qingdao Haier Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Qingdao Haier appears to be risky and price may revert if volatility continues | |
| About 40.0% of the company shares are owned by insiders or employees |
- Analyzing Qingdao Haier's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qingdao Haier's stock is overvalued or undervalued compared to its peers.
- Examining Qingdao Haier's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qingdao Haier's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qingdao Haier's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Qingdao Haier's stock. These opinions can provide insight into Qingdao Haier's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Qingdao Stock analysis
When running Qingdao Haier's price analysis, check to measure Qingdao Haier's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qingdao Haier is operating at the current time. Most of Qingdao Haier's value examination focuses on studying past and present price action to predict the probability of Qingdao Haier's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qingdao Haier's price. Additionally, you may evaluate how the addition of Qingdao Haier to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |